Although surgery alone represents a curative approach for patients with pT3N0M0 colon cancer, about 15â20Â % of these patients develop a relapse of disease. Microsatellite instability (MSI) is one of the most important molecular markers in colorectal cancer. The aim of this study was to investigate the prognostic relevance of MSI in all pT3N0M0 tumors recorded in the Cancer Registry of the Province of Modenaâ(Northern Italy) within the 2002â2006 period in patients who showed a relapse of disease during the 5-year period of follow-up (59 cases). They were compared to 59 controls similar in clinical and pathological features but with good prognosis. None of the subjects received adjuvant chemotherapy. MSI status was tested using BAT25, BAT26, NR24, and CAT25 fluorescent-labeled mononucleotide markers. The overall prevalence of MSI was 12.7Â % (15 of 118 cases). MSI was detected mainly in mucinous adenocarcinoma (pÂ
Prognostic relevance of microsatellite instability in pT3N0M0 colon cancer: a population-based study / Iachetta, Francesco; Domati, Federica; Reggiani-Bonetti, Luca; Barresi, Valeria; Magnani, Giulia; Marcheselli, Luigi; Cirilli, Claudia; Pedroni, Monica. - In: INTERNAL AND EMERGENCY MEDICINE. - ISSN 1828-0447. - 11:1(2016), pp. 41-46. [10.1007/s11739-015-1285-6]
Prognostic relevance of microsatellite instability in pT3N0M0 colon cancer: a population-based study
Iachetta, Francesco;Domati, Federica;Reggiani-Bonetti, Luca;Magnani, Giulia;Marcheselli, Luigi;Pedroni, Monica
2016
Abstract
Although surgery alone represents a curative approach for patients with pT3N0M0 colon cancer, about 15â20Â % of these patients develop a relapse of disease. Microsatellite instability (MSI) is one of the most important molecular markers in colorectal cancer. The aim of this study was to investigate the prognostic relevance of MSI in all pT3N0M0 tumors recorded in the Cancer Registry of the Province of Modenaâ(Northern Italy) within the 2002â2006 period in patients who showed a relapse of disease during the 5-year period of follow-up (59 cases). They were compared to 59 controls similar in clinical and pathological features but with good prognosis. None of the subjects received adjuvant chemotherapy. MSI status was tested using BAT25, BAT26, NR24, and CAT25 fluorescent-labeled mononucleotide markers. The overall prevalence of MSI was 12.7Â % (15 of 118 cases). MSI was detected mainly in mucinous adenocarcinoma (pÂFile | Dimensione | Formato | |
---|---|---|---|
Iachetta2016_Article_PrognosticRelevanceOfMicrosate.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
346.31 kB
Formato
Adobe PDF
|
346.31 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris